Watch: 13 people with Parkinson’s on the impact of exercise
Health & Fitness
Author: Saskia MairPublished: 21 May 2020
Prep: Cook: Serves:
“What are the benefits of exercise?” A new global video project sees people with Parkinson’s share how staying active has helped them manage their symptoms – and encourages others with the condition to join in
People with Parkinson’s around the world – from Wales to
Peru and Canada to New Zealand –share how exercise has impacted their life with
the condition in a new video project.
In ‘What are the benefits of exercise?’ and ‘What keeps you motivated?’, participants show their routines – from weightlifting and running, to cycling and boxing – discuss the challenges they’ve faced, and highlight the effects of regular exercise, which include improving balance and posture, and supporting mental health.
They also contribute fitness tips for those who struggle to form a workout habit. “Find what you enjoy and use that to keep yourself moving,” suggests John Reyes from the USA who was diagnosed with Parkinson’s aged 36, while Jonny Acheson from the UK, who was diagnosed aged 41, recommends setting “a goal or challenge – and if at first you don’t succeed, just keep trying”.
Video creator Christine Jeyachandran, who lives in Peru, was diagnosed with the condition aged 37 and took up gymnastics to help manage her symptoms. She says that the experience inspired her to organise the project.
that I’d go whether I felt like it or not. As I advanced and improved my range
of movement, it encouraged me to try harder things. I had to overcome apathy, doubts, fatigue and fear to get serious
about exercising – but the benefits have been worth the effort.”
Christine has also made a ‘Before and After’ video, demonstrating how her symptoms have improved since starting her exercise routine. But, she says, showcasing stories from people of different ages, with varying experiences, is essential to persuade others to keep fit.
“I didn’t want people to say: ‘I couldn’t do that – you are younger and less affected than me’. So, I asked if others had benefited from exercise, and the videos say it all. These stories communicate with people with Parkinson’s better than scientific studies.”
And, although many are confined to their homes during the
coronavirus pandemic, it’s still vital to keep moving.
“Society might be in lockdown, but Parkinson’s disease is
ongoing,” she says. “In these times, it is harder to keep self-motivated, and if
I don’t exercise my body stiffens up and dyskinesia increases.
“Being stuck in an apartment gets to me, but when I do my
abdominal workout I feel so much better.”
Exercise and Parkinson’s
Research indicates that exercise can be neuroprotective – meaning it can slow down the progression of Parkinson’s. It can also provide physiological benefits
Ask for professional medical advice to find activities that suit your fitness and mobility level
Include a mixture of stretching, strengthening, weight bearing and balance exercises, alongside aerobic activity
Make sure you warm up first, and don’t try to do too much too quickly
Kim Petrie: “How I raised $250,000 for Parkinson’s research”
Kim Petrie tells us how she raised $250,000 to fight Parkinson’s
3 days ago
Diesel exhaust fumes may increase the risk of Parkinson’s, study suggests
A new study by researchers in the US has found evidence that chemicals in diesel exhaust fumes can damage brain cells – and potentially increase the risk of Parkinson’s. As part of the study – published in ‘Toxicological Sciences’ – researchers tested the effects of diesel exhaust fumes on zebrafish, as their neurons interact in a similar way to those of humans. The researchers found that after being exposed to the chemicals, the zebrafish had fewer cells that dispose of toxic build-up of the protein alpha-synuclein, which occurs in Parkinson’s. The researchers replicated the experiment with cultured human cells and found similar results. Dr Jeff Bronstein, a professor of neurology at the University of California, Los Angeles (UCLA), US, said: “Overall, this report shows a plausible mechanism of why air pollution may increase the risk of Parkinson’s disease.”
Can Covid-19 increase the risk of developing Parkinson’s?
Parkinson’s could be caused or modulated by infections like Covid-19, a new study suggests – though more evidence is needed to draw a definitive conclusion. As part of the study, researchers from the Federal University of São Paulo, Brazil, drew on previous findings to support their hypothesis. For example, studies in mice have found that infection with some strains of influenza could cause neural changes similar to those in Parkinson’s. Furthermore, people born during or around the 1918 influenza pandemic were over twice as likely to develop Parkinson’s than those born in the decades before or after. Patrik Brundin, co-editor-in-chief of the Journal of Parkinson’s Disease, said that while it’s “too early to know what the long-term consequences of Covid-19 will be on the brain, the clinical psychiatry and neurology research communities definitely need to be vigilant in monitoring how those who recover from moderate and severe Covid-19 fare in…
New Parkinson’s trial platform could “dramatically speed up the search for a cure”
Scientists have proposed the use of a multi-arm, multi-stage trial platform (MAMS) to assess different potential treatments for Parkinson’s and help progress the search for a cure. This would depart from conventional clinical procedures, allowing several potential treatments to be assessed simultaneously. In a continuous process, each treatment ‘arm’ is evaluated and unsuccessful ‘arms’ of the trial are dropped, enabling a far more cost and time efficient system. Currently, MAMS are used to evaluate treatments for certain types of cancer – and work is underway to develop MAMS for other neurodegenerative conditions. Camille Buchholz Carroll, associate professor at the University of Plymouth, UK, and study author, said that MAMS trials could “dramatically speed up the search for a cure”. She said: “We have the opportunity to learn from the experience in these other conditions and design a new trial that will work for people with Parkinson’s.”